182 related articles for article (PubMed ID: 12657723)
1. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.
Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D
Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of novel anti-cancer agents targeting aurora kinases.
Mahadevan D; Bearss DJ; Vankayalapati H
Curr Med Chem Anticancer Agents; 2003 Jan; 3(1):25-34. PubMed ID: 12678912
[TBL] [Abstract][Full Text] [Related]
3. Aurora kinases.
Bolanos-Garcia VM
Int J Biochem Cell Biol; 2005 Aug; 37(8):1572-7. PubMed ID: 15896667
[TBL] [Abstract][Full Text] [Related]
4. The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation.
Walter AO; Seghezzi W; Korver W; Sheung J; Lees E
Oncogene; 2000 Oct; 19(42):4906-16. PubMed ID: 11039908
[TBL] [Abstract][Full Text] [Related]
5. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma.
Hamada M; Yakushijin Y; Ohtsuka M; Kakimoto M; Yasukawa M; Fujita S
Br J Haematol; 2003 May; 121(3):439-47. PubMed ID: 12716366
[TBL] [Abstract][Full Text] [Related]
6. PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy.
Jani JP; Arcari J; Bernardo V; Bhattacharya SK; Briere D; Cohen BD; Coleman K; Christensen JG; Emerson EO; Jakowski A; Hook K; Los G; Moyer JD; Pruimboom-Brees I; Pustilnik L; Rossi AM; Steyn SJ; Su C; Tsaparikos K; Wishka D; Yoon K; Jakubczak JL
Mol Cancer Ther; 2010 Apr; 9(4):883-94. PubMed ID: 20354118
[TBL] [Abstract][Full Text] [Related]
7. Structures of staurosporine bound to CDK2 and cAPK--new tools for structure-based design of protein kinase inhibitors.
Toledo LM; Lydon NB
Structure; 1997 Dec; 5(12):1551-6. PubMed ID: 9438871
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase.
Sun C; Newbatt Y; Douglas L; Workman P; Aherne W; Linardopoulos S
J Biomol Screen; 2004 Aug; 9(5):391-7. PubMed ID: 15296638
[TBL] [Abstract][Full Text] [Related]
9. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.
Bischoff JR; Anderson L; Zhu Y; Mossie K; Ng L; Souza B; Schryver B; Flanagan P; Clairvoyant F; Ginther C; Chan CS; Novotny M; Slamon DJ; Plowman GD
EMBO J; 1998 Jun; 17(11):3052-65. PubMed ID: 9606188
[TBL] [Abstract][Full Text] [Related]
10. Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach.
Warner SL; Bashyam S; Vankayalapati H; Bearss DJ; Han H; Mahadevan D; Von Hoff DD; Hurley LH
Mol Cancer Ther; 2006 Jul; 5(7):1764-73. PubMed ID: 16891462
[TBL] [Abstract][Full Text] [Related]
11. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.
Songyang Z; Lu KP; Kwon YT; Tsai LH; Filhol O; Cochet C; Brickey DA; Soderling TR; Bartleson C; Graves DJ; DeMaggio AJ; Hoekstra MF; Blenis J; Hunter T; Cantley LC
Mol Cell Biol; 1996 Nov; 16(11):6486-93. PubMed ID: 8887677
[TBL] [Abstract][Full Text] [Related]
12. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002.
Jacobs MD; Black J; Futer O; Swenson L; Hare B; Fleming M; Saxena K
J Biol Chem; 2005 Apr; 280(14):13728-34. PubMed ID: 15657054
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
[TBL] [Abstract][Full Text] [Related]
15. Activation of calcium/calmodulin regulated kinases.
Wilmann M; Gautel M; Mayans O
Cell Mol Biol (Noisy-le-grand); 2000 Jul; 46(5):883-94. PubMed ID: 10976872
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of STK12/Aik2: a human gene related to aurora of Drosophila and yeast IPL1.
Kimura M; Matsuda Y; Yoshioka T; Sumi N; Okano Y
Cytogenet Cell Genet; 1998; 82(3-4):147-52. PubMed ID: 9858806
[TBL] [Abstract][Full Text] [Related]
17. Cdc20 associates with the kinase aurora2/Aik.
Farruggio DC; Townsley FM; Ruderman JV
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7306-11. PubMed ID: 10377410
[TBL] [Abstract][Full Text] [Related]
18. Insights into autoregulation from the crystal structure of twitchin kinase.
Hu SH; Parker MW; Lei JY; Wilce MC; Benian GM; Kemp BE
Nature; 1994 Jun; 369(6481):581-4. PubMed ID: 8202162
[TBL] [Abstract][Full Text] [Related]
19. Giant protein kinases: domain interactions and structural basis of autoregulation.
Kobe B; Heierhorst J; Feil SC; Parker MW; Benian GM; Weiss KR; Kemp BE
EMBO J; 1996 Dec; 15(24):6810-21. PubMed ID: 9003756
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
